These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


686 related items for PubMed ID: 19577499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P, Schrenk P, Reitsamer R, Koeberle-Wuehrer R, Tausch C, Roka S, Riedl O, Poestlberger S, Hecke D, Janauer M, Haid A.
    Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
    [Abstract] [Full Text] [Related]

  • 4. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 5. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.
    Ann Surg Oncol; 2010 Feb 01; 17(2):552-7. PubMed ID: 19957043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D.
    Bull Cancer; 2008 Feb 01; 95(7):763-72. PubMed ID: 18755653
    [Abstract] [Full Text] [Related]

  • 8. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM.
    Eur J Surg Oncol; 2007 Sep 01; 33(7):832-7. PubMed ID: 17197151
    [Abstract] [Full Text] [Related]

  • 9. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
    Coutant C, Rouzier R, Fondrinier E, Marchal F, Guillemin F, Seince N, Rodrigues A, Darai E, Uzan S, Barranger E.
    Breast Cancer Res Treat; 2009 Feb 01; 113(3):537-43. PubMed ID: 18340527
    [Abstract] [Full Text] [Related]

  • 10. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
    Haid A, Koeberle-Wuehrer R, Offner F, Jasarevic Z, Fritzsche H, Zimmermann G.
    Chirurg; 2003 Jul 01; 74(7):657-64. PubMed ID: 12883794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A, Benitez A, Bajén MT, Pla MJ, Gil M, Martín-Comín J.
    Oncology; 2007 Jul 01; 72(1-2):27-32. PubMed ID: 17998787
    [Abstract] [Full Text] [Related]

  • 15. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 Jul 01; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA.
    Eur J Surg Oncol; 2009 Feb 01; 35(2):159-63. PubMed ID: 18789841
    [Abstract] [Full Text] [Related]

  • 18. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
    Jones JL, Zabicki K, Christian RL, Gadd MA, Hughes KS, Lesnikoski BA, Rhei E, Specht MC, Dominguez FJ, Smith BL.
    Am J Surg; 2005 Oct 01; 190(4):517-20. PubMed ID: 16164912
    [Abstract] [Full Text] [Related]

  • 19. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S.
    Breast Cancer Res Treat; 2005 May 01; 91(2):113-9. PubMed ID: 15868438
    [Abstract] [Full Text] [Related]

  • 20. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.
    J Clin Oncol; 2009 Jun 20; 27(18):2946-53. PubMed ID: 19364968
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.